TCL Archive ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies June 22, 2012
TCL Archive More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene August 28, 2009
TCL Archive Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991 November 9, 1990
TCL Archive Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve February 21, 1975
